GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (STU:PX91) » Definitions » Pre-Tax Income

Cassava Sciences (STU:PX91) Pre-Tax Income : €-15.60 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Cassava Sciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cassava Sciences's pretax income for the three months ended in Sep. 2024 was €-25.18 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was €-15.60 Mil. Cassava Sciences's pretax margin was %.


Cassava Sciences Pre-Tax Income Historical Data

The historical data trend for Cassava Sciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences Pre-Tax Income Chart

Cassava Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.17 -5.21 -28.66 -71.98 -89.15

Cassava Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.04 -19.18 23.04 5.72 -25.18

Competitive Comparison of Cassava Sciences's Pre-Tax Income

For the Biotechnology subindustry, Cassava Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cassava Sciences's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cassava Sciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cassava Sciences's Pre-Tax Income falls into.



Cassava Sciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cassava Sciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-97.163+0.832+0+7.183+0
=-89.15

Cassava Sciences's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-27.591+0.056+0+2.359+-0.00099999999999767
=-25.18

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-15.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cassava Sciences  (STU:PX91) Pre-Tax Income Explanation

Cassava Sciences's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-25.177/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cassava Sciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cassava Sciences Business Description

Traded in Other Exchanges
Address
6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.

Cassava Sciences Headlines

No Headlines